(Q37679957)

21 August 2017

1 reference

title

What should be considered on design of a colon-specific prodrug? (English)

1 reference

21 August 2017

Yunjin Jung

1

1 reference

21 August 2017

Young Mi Kim

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Drug Delivery

21 August 2017

published in

1 reference

21 August 2017

volume

7

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

245-258

1 reference

Development and characterization of drug delivery systems for targeting mammalian cells and tissues: a review

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug targeting to specific vascular sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug-targeting strategies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Specific drug delivery to the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug targeting to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Targeted drug delivery to bone: pharmacokinetic and pharmacological properties of acidic oligopeptide-tagged drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Progress in drug delivery to the central nervous system by the prodrug approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Colonic drug delivery: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Recent trends in targeted anticancer prodrug and conjugate design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Therapeutic opportunities in colon-specific drug-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Oral colon-specific drug delivery of protein and peptide drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

New oral delivery systems for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Colonic drug delivery: prodrug approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Influence of molecular weight on oral absorption of water soluble chitosans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Membrane transport of drugs in different regions of the intestinal tract of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis andin vitro properties of prednisolone 21-sulfate sodium as a colon-specific prodrug of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Biorecognizable HPMA copolymer-drug conjugates for colon-specific delivery of 9-aminocamptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Microbially triggered drug delivery to the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Gut flora in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Influence of inflammatory bowel disease on intestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug therapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis and evaluation of N-nicotinoyl-2-{2-(2-methyl-5-nitroimidazol-1-yl)ethyloxy}-D,L-glycine as a colon-specific prodrug of metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis and evaluation of N-acyl-2-(5-fluorouracil-1-yl)-D,L-glycine as a colon-specific prodrug of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Development of colon targeted drug delivery systems for mebendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Use of azo polymers for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Design of novel bioconjugates for targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Poly(ethylene glycol)-mesalazine conjugate for colon specific delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

N,N'-Bis(5-aminosalicyl)-L-cystine is a potential colon-specific 5-aminosalicylic acid prodrug with dual therapeutic effects in experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

A molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug therapy of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Drug glycosides: potential prodrugs for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

A budesonide prodrug accelerates treatment of colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Prednisolone 21-sulfate sodium: a colon-specific pro-drug of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Preparation of prednisolone-appended alpha-, beta- and gamma-cyclodextrins: substitution at secondary hydroxyl groups and in vitro hydrolysis behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Clinical pharmacology of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis and properties of 5-aminosalicyl-taurine as a colonspecific prodrug of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Reduction of Azo Food Dyes in Cultures ofProteus vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Colon-specific 9-aminocamptothecin-HPMA copolymer conjugates containing a 1,6-elimination spacer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

Glycosidases in the Mammalian Alimentary Tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425240903490401

10.1517/17425240903490401

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference